Perceptive-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "AKRO",
  "NUVL",
  "AXSM",
  "EWTX",
  "CNTA",
  "RGEN",
  "INSM",
  "ARGX",
  "AORT",
  "MDGL",
  "FOLD",
  "ADMA",
  "BSX",
  "MREO",
  null,
  "RCKT",
  "ADPT",
  "ATXS",
  "IMTX",
  "NRIX",
  "ACRV",
  "ADGM",
  "ALDX",
  "AVTX",
  "ATHA",
  "AMLX",
  "JANX",
  "APYX",
  "AVR",
  "APLT",
  null,
  null,
  "CTNM",
  "SYRE",
  "APGE",
  "ISRG",
  null,
  "INBX",
  "NBIX",
  "KALA",
  "LXEO",
  "NAUT",
  null,
  "OKUR",
  null,
  "IOVA",
  "BDSX",
  null,
  "IKT",
  "NBTX",
  null,
  null,
  "PODD",
  "ZYME",
  "RAPT",
  "PTGX",
  "TRAW",
  "SLDB",
  "PRAX",
  "AQST",
  "LYRA",
  "RYTM",
  "SLNO",
  "ACLX",
  "DYN",
  "SCPH",
  null,
  "DCTH",
  "EOLS",
  "EYPT",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "OBIO",
  null,
  "IMVT",
  "PCVX",
  "CRGX",
  "CELC",
  "CGEM",
  "DXCM",
  "IRON",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 86
Total Value: 2694161578
Accession Number: 0001012975-25-000242
Form Type: 13F-HR
CIK: perceptive-advisors
Manager Name: Perceptive-Advisors

Data Enrichment

87% identified

75 identified11 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

86 positions • $2.7B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 5

Sort by:

Spyre Therapeutics, Inc.

SYRE|00773J202

Shares:2.3M

Value:$37.3M

% of Portfolio:1.4% ($37.3M/$2.7B)

Praxis Precision Medicines, Inc.

PRAX|74006W207

Shares:980.9K

Value:$37.1M

% of Portfolio:1.4% ($37.1M/$2.7B)

ARGENX SE

ARGX|04016X101

Shares:59.5K

Value:$35.2M

% of Portfolio:1.3% ($35.2M/$2.7B)

Astria Therapeutics, Inc.

ATXS|04635X102

Shares:6.5M

Value:$34.6M

% of Portfolio:1.3% ($34.6M/$2.7B)

Akero Therapeutics, Inc.

AKRO|00973Y108

Shares:793.0K

Value:$32.1M

% of Portfolio:1.2% ($32.1M/$2.7B)

Merus N.V.

MRUS|N5749R100

Shares:690.5K

Value:$29.1M

% of Portfolio:1.1% ($29.1M/$2.7B)

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:7.9M

Value:$27.9M

% of Portfolio:1.0% ($27.9M/$2.7B)

ADMA BIOLOGICS, INC.

ADMA|000899104

Shares:1.4M

Value:$27.2M

% of Portfolio:1.0% ($27.2M/$2.7B)

08659B102

Shares:2.2M

Value:$27.0M

% of Portfolio:1.0% ($27.0M/$2.7B)

Vaxcyte, Inc.

PCVX|92243G108

Shares:706.6K

Value:$26.7M

% of Portfolio:1.0% ($26.7M/$2.7B)

Janux Therapeutics, Inc.

JANX|47103J105

Shares:970.4K

Value:$26.2M

% of Portfolio:1.0% ($26.2M/$2.7B)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:2.3M

Value:$24.2M

% of Portfolio:0.9% ($24.2M/$2.7B)

Celcuity Inc.

CELC|15102K100

Shares:2.4M

Value:$23.9M

% of Portfolio:0.9% ($23.9M/$2.7B)

Zymeworks Inc.

ZYME|98985Y108

Shares:1.9M

Value:$22.2M

% of Portfolio:0.8% ($22.2M/$2.7B)

INTUITIVE SURGICAL INC

ISRG|46120E602

Shares:40.6K

Value:$20.1M

% of Portfolio:0.7% ($20.1M/$2.7B)

Orchestra BioMed Holdings, Inc.

OBIO|68572M106

Shares:4.6M

Value:$19.7M

% of Portfolio:0.7% ($19.7M/$2.7B)

INSULET CORP

PODD|45784P101

Shares:71.6K

Value:$18.8M

% of Portfolio:0.7% ($18.8M/$2.7B)

REPLIGEN CORP

RGEN|759916109

Shares:129.8K

Value:$16.5M

% of Portfolio:0.6% ($16.5M/$2.7B)

10919W405

Shares:444.6K

Value:$16.0M

% of Portfolio:0.6% ($16.0M/$2.7B)

MADRIGAL PHARMACEUTICALS, INC.

MDGL|558868105

Shares:46.5K

Value:$15.4M

% of Portfolio:0.6% ($15.4M/$2.7B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Spyre Therapeutics, Inc.(SYREcusip00773J202)	2.3M	QoQ -10.15% (-261.5K) YoY -9.52% (-243.4K)	All Managers (Combined)	$37.3M	1.4% ($37.3M/$2.7B)	QoQ -37.72% (-$22.6M) YoY -61.51% (-$59.7M)
Praxis Precision Medicines, Inc.(PRAXcusip74006W207)	980.9K	QoQ +96.17% (-480.9K) YoY +19.38% (-159.3K)	All Managers (Combined)	$37.1M	1.4% ($37.1M/$2.7B)	QoQ -3.46% (-$1.3M) YoY -25.90% (-$13.0M)
ARGENX SE(ARGXcusip04016X101)	59.5K	QoQ -11.79% (-8.0K) YoY NEW(+59.5K)	All Managers (Combined)	$35.2M	1.3% ($35.2M/$2.7B)	QoQ -15.11% (-$6.3M) YoY NEW(+$35.2M)
Astria Therapeutics, Inc.(ATXScusip04635X102)	6.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$34.6M	1.3% ($34.6M/$2.7B)	QoQ -40.26% (-$23.3M) YoY -62.04% (-$56.6M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	793.0K	QoQ -33.11% (-392.6K) YoY -42.84% (-594.5K)	All Managers (Combined)	$32.1M	1.2% ($32.1M/$2.7B)	QoQ -2.68% (-$884.1K) YoY -8.41% (-$2.9M)
Merus N.V.(MRUScusipN5749R100)	690.5K	QoQ +130.16% (+390.5K) YoY NEW(+690.5K)	All Managers (Combined)	$29.1M	1.1% ($29.1M/$2.7B)	QoQ +130.38% (+$16.4M) YoY NEW(+$29.1M)
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	7.9M	QoQ +16.23% (+1.1M) YoY +2524.78% (+7.6M)	All Managers (Combined)	$27.9M	1.0% ($27.9M/$2.7B)	QoQ +8.85% (+$2.3M) YoY +3171.73% (+$27.0M)
ADMA BIOLOGICS, INC.(ADMAcusip000899104)	1.4M	QoQ +54.24% (+483.0K) YoY -78.65% (-5.1M)	All Managers (Combined)	$27.2M	1.0% ($27.2M/$2.7B)	QoQ +78.44% (+$12.0M) YoY -35.83% (-$15.2M)
(cusip08659B102)✕	2.2M	QoQ NEW(+2.2M) YoY NEW(+2.2M)	All Managers (Combined)	$27.0M	1.0% ($27.0M/$2.7B)	QoQ NEW(+$27.0M) YoY NEW(+$27.0M)
Vaxcyte, Inc.(PCVXcusip92243G108)	706.6K	QoQ -58.88% (-1.0M) YoY -63.44% (-1.2M)	All Managers (Combined)	$26.7M	1.0% ($26.7M/$2.7B)	QoQ -81.03% (-$114.0M) YoY -79.79% (-$105.3M)
Janux Therapeutics, Inc.(JANXcusip47103J105)	970.4K	QoQ +18.64% (-152.5K) YoY NEW(+970.4K)	All Managers (Combined)	$26.2M	1.0% ($26.2M/$2.7B)	QoQ -40.16% (-$17.6M) YoY NEW(+$26.2M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	2.3M	QoQ +325.82% (+1.8M) YoY NEW(+2.3M)	All Managers (Combined)	$24.2M	0.9% ($24.2M/$2.7B)	QoQ +89.05% (+$11.4M) YoY NEW(+$24.2M)
Celcuity Inc.(CELCcusip15102K100)	2.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$23.9M	0.9% ($23.9M/$2.7B)	QoQ -22.76% (-$7.0M) YoY -53.19% (-$27.1M)
Zymeworks Inc.(ZYMEcusip98985Y108)	1.9M	QoQ -12.45% (-265.3K) YoY +73.48% (+789.9K)	All Managers (Combined)	$22.2M	0.8% ($22.2M/$2.7B)	QoQ -28.78% (-$9.0M) YoY +96.41% (+$10.9M)
INTUITIVE SURGICAL INC(ISRGcusip46120E602)	40.6K	QoQ -35.64% (-22.5K) YoY -60.09% (-61.2K)	All Managers (Combined)	$20.1M	0.7% ($20.1M/$2.7B)	QoQ -38.93% (-$12.8M) YoY -50.48% (-$20.5M)
Orchestra BioMed Holdings, Inc.(OBIOcusip68572M106)	4.6M	QoQ 0.00% (+0) YoY +80.39% (+2.0M)	All Managers (Combined)	$19.7M	0.7% ($19.7M/$2.7B)	QoQ +7.00% (+$1.3M) YoY +46.50% (+$6.2M)
INSULET CORP(PODDcusip45784P101)	71.6K	QoQ -69.17% (-160.7K) YoY NEW(+71.6K)	All Managers (Combined)	$18.8M	0.7% ($18.8M/$2.7B)	QoQ -68.99% (-$41.8M) YoY NEW(+$18.8M)
REPLIGEN CORP(RGENcusip759916109)	129.8K	QoQ NEW(+129.8K) YoY NEW(+129.8K)	All Managers (Combined)	$16.5M	0.6% ($16.5M/$2.7B)	QoQ NEW(+$16.5M) YoY NEW(+$16.5M)
(cusip10919W405)✕	444.6K	QoQ +10.15% (+41.0K) YoY NEW(+444.6K)	All Managers (Combined)	$16.0M	0.6% ($16.0M/$2.7B)	QoQ +10.31% (+$1.5M) YoY NEW(+$16.0M)
MADRIGAL PHARMACEUTICALS, INC.(MDGLcusip558868105)	46.5K	QoQ NEW(+46.5K) YoY -89.18% (-383.5K)	All Managers (Combined)	$15.4M	0.6% ($15.4M/$2.7B)	QoQ NEW(+$15.4M) YoY -86.58% (-$99.4M)